Our observation of increased microgliosis and astrocytosis post rCHI in P301S mice in the absence of tau pathology and behavioral dysfunction or neuronal loss points to a potential parallel mechanism to that observed in AD where the inflammatory response develops likely as a result of amyloid-β deposition and thereafter contributes to the development of tau pathology and cognitive dysfunction [53]. The gene discussed is MAPT; the disease is Alzheimer disease.